Munafa Stock Market Course + Intraday & FNO calls 
Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Akari Therapeutics (AKTX)
Technical Analysis Report for USA stock AKTX Akari Therapeutics. Dated: 04 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock AKTX Akari Therapeutics then click here. or read Experts views on Akari Therapeutics or Forecast & share price targets of Akari Therapeutics
Akari Therapeutics Opened at 0.33 and Closed at: 0.34, which is 0% of previous session's close. It moved within a range of 0.30 and 0.36
The session was a Bullish session with an average volume of 488314, which is -60.04% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 0.32 and resistance for tomorrow is 0.38
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.31, 0.27 resistance for tomorrow's hourly charts is 0.37, 0.39
10 Day SMA for Akari Therapeutics (AKTX) is 0.42 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Akari Therapeutics (AKTX) is 0.49 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Akari Therapeutics (AKTX) is 0.72 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.82 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Akari Therapeutics is 1.01 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Akari Therapeutics is at 0.49 and 200 DMA is at 1.01, while 50 DMA and 100 DMA are at 0.72 and 0.82 respectively
Akari Therapeutics (AKTX) moving average of 20 SMA is at 0.49 and 20 EMA is at 0.48
| Date | Closing Price | 20 SMA | 20 EMA |
| 04 Thu Dec | 0.34 | 0.49 | 0.48 |
| 03 Wed Dec | 0.34 | 0.51 | 0.5 |
| 02 Tue Dec | 0.35 | 0.53 | 0.52 |
| 01 Mon Dec | 0.40 | 0.55 | 0.54 |
| 28 Fri Nov | 0.49 | 0.57 | 0.55 |
| 26 Wed Nov | 0.45 | 0.58 | 0.56 |
Akari Therapeutics (AKTX) moving average of 50 SMA is at 0.72 and 50 EMA is at 0.65
| Date | Closing Price | 50 SMA | 50 EMA |
| 04 Thu Dec | 0.34 | 0.72 | 0.65 |
| 03 Wed Dec | 0.34 | 0.73 | 0.66 |
| 02 Tue Dec | 0.35 | 0.74 | 0.67 |
| 01 Mon Dec | 0.40 | 0.75 | 0.68 |
| 28 Fri Nov | 0.49 | 0.76 | 0.69 |
| 26 Wed Nov | 0.45 | 0.76 | 0.7 |
Akari Therapeutics (AKTX) moving average of 100 SMA is at 0.82 and 100 EMA is at 0.77
| Date | Closing Price | 100 SMA | 100 EMA |
| 04 Thu Dec | 0.34 | 0.82 | 0.77 |
| 03 Wed Dec | 0.34 | 0.83 | 0.78 |
| 02 Tue Dec | 0.35 | 0.84 | 0.79 |
| 01 Mon Dec | 0.40 | 0.85 | 0.8 |
| 28 Fri Nov | 0.49 | 0.85 | 0.81 |
| 26 Wed Nov | 0.45 | 0.86 | 0.82 |
Akari Therapeutics (AKTX) moving average of 200 SMA is at 1.01 and 200 EMA is at 1.02
| Date | Closing Price | 200 SMA | 200 EMA |
| 04 Thu Dec | 0.34 | 1.01 | 1.02 |
| 03 Wed Dec | 0.34 | 1.01 | 1.03 |
| 02 Tue Dec | 0.35 | 1.01 | 1.04 |
| 01 Mon Dec | 0.40 | 1.02 | 1.05 |
| 28 Fri Nov | 0.49 | 1.02 | 1.06 |
| 26 Wed Nov | 0.45 | 1.03 | 1.07 |
Zimmer Biomet has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Zimmer Biomet, about 50.41% more returns!
Takeda Pharmaceutical has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 49.85% more returns!
Arcus Biosciences has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Arcus Biosciences, about 74.3% more returns!
Novartis Ag has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Novartis Ag, about 49.79% more returns!
Laboratory Corporation has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Laboratory Corporation, about 51.18% more returns!
Haemonetics Corporation has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Haemonetics Corporation, about 70.04% more returns!
Radnet Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Radnet Inc, about 47.91% more returns!
Pavmed Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Pavmed Inc, about 54.84% more returns!
Nektar Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 49.82% more returns!
Neurocrine Biosciences has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 44.79% more returns!
Meiragtx Holdings has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Meiragtx Holdings, about 47.42% more returns!
Jazz Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Jazz Pharmaceuticals, about 69.67% more returns!
Ionis Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Ionis Pharmaceuticals, about 55.56% more returns!
Immutep has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Immutep, about 53.04% more returns!
Cooper Companies has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Cooper Companies, about 56.61% more returns!
Aquestive Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Aquestive Therapeutics, about 50.38% more returns!
Aptevo Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Aptevo Therapeutics, about 39.72% more returns!
Alnylam Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Alnylam Pharmaceuticals, about 50.8% more returns!
Arbutus Biopharma has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Arbutus Biopharma, about 44.48% more returns!
Akari Therapeutics Technical analysis of indicators
Price action analysis of Akari Therapeutics (AKTX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Akari Therapeutics in short term and the sell signal is strong.
Akari Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Akari Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akari Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.35 and Akari Therapeutics AKTX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Akari Therapeutics AKTX stock. Volume based technical analysis of Akari Therapeutics AKTX stock is negative.
Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock AKTX Akari Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AKTX Experts View which covers a lot of information including buying and selling signals
AKTX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akari Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
